burgercaret-downcaret-rightShape CopycloseGroup 19Group 16Group 17document-addMaterial/Icons white/Edit or CreateCombined ShapeShapeGroup 10Group 4Page 1Group 7Fill 1GroupGroup 31Group 21 CopyCombined ShapeShape

Statement of Rahna Epting, Executive Director of MoveOn, on Drug Reform Measures in Reconciliation

Democrats who are looking to gut much needed prescription drug pricing reform from the reconciliation package — which would lower the price of life saving prescription drugs for tens of millions of Americans — need to take a long look in the mirror and assess whether they are representing their constituents or doing the backroom bidding of Big Pharma and their army of lobbyists. Because all available evidence at the moment points to Representatives Rice, Schrader, and Peters being more interested in lining the pockets of rich pharmaceutical CEOs rather than delivering relief from the price gouging costs of prescription drugs for their constituents. Congress has a once-in-a-generation chance to enact big and bold reforms. Democrats looking to water them down on behalf of special interests are actively harming the people they’re supposed to serve.